Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack – The Randomized Controlled Trial
2024-517343-31-00Phase 4Authorised
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of pravastatin, fluvastatin, rosuvastatin, simvastatin and atorvastatin in ischemic stroke and transient ischaemic attack (TIA) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: MACE-free survival over two years and Health-related quality of life (PROMIS-10). Planned start Dec 2024; status: authorised.
02
Drugs
pravastatinfluvastatinrosuvastatinsimvastatinatorvastatin
03
Conditions
ischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on 2024-517343-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517343-31-00.